Research location
Clydebank
United Kingdom
Advertisement
Research activity in Clydebank
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 34 trials and 34 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Clydebank
34 linked trials · page 1 of 1A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24 · 1 site observation
RECRUITING
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartNCT06935370 · 2025-05-20 · 1 site observation
RECRUITING
A Trial of "APL-9796'' in Adults With Pulmonary HypertensionNCT06846554 · 2025-04-09 · 1 site observation
RECRUITING
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)NCT06274801 · 2024-09-03 · 1 site observation
RECRUITING
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionNCT06307652 · 2024-04-12 · 1 site observation
RECRUITING
Biomarkers for the Assessment of Congestion in Patients With Ambulatory and Hospitalised Heart FailureNCT06459999 · 2024-06-01 · 1 site observation
UNKNOWN
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)NCT05934526 · 2023-12-28 · 1 site observation
COMPLETED
A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2NCT05737940 · 2023-04-24 · 1 site observation
COMPLETED
A Study of Ponsegromab in People With Heart FailureNCT05492500 · 2022-09-26 · 1 site observation
TERMINATED
Effectiveness of CRD-740 in Heart FailureNCT05409183 · 2022-05-26 · 1 site observation
TERMINATED
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.NCT04564742 · 2020-12-22 · 1 site observation
COMPLETED
Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus GlobalNCT04236609 · 2020-06-15 · 1 site observation
UNKNOWN
Safety and Efficacy of BIA 5-1058 in PAHNCT06009185 · 2019-06-26 · 1 site observation
COMPLETED
Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat)NCT04316143 · 2019-06-03 · 1 site observation
COMPLETED
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)NCT03496207 · 2018-06-13 · 1 site observation
COMPLETED
Precision Event Monitoring for Patients With Heart Failure Using HeartLogicNCT03579641 · 2018-06-01 · 1 site observation
COMPLETED
Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation
COMPLETED
Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.NCT03078907 · 2017-11-08 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart FailureNCT03036124 · 2017-02-08 · 1 site observation
COMPLETED
EU Multicenter Registry to Assess Outcomes in CABG Patients: Treatment of Vascular Conduits With DuraGraft [VASC]NCT02922088 · 2016-12-09 · 1 site observation
UNKNOWN
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial HypertensionNCT02558231 · 2016-05-01 · 1 site observation
COMPLETED
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.NCT01918215 · 2015-07-01 · 1 site observation
COMPLETED
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)NCT01894022 · 2014-01-23 · 1 site observation
TERMINATED
Zimmer POLAR Persona - TKA (EMEA Study)NCT02337244 · 2013-11-18 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureNCT01877915 · 2013-09-10 · 1 site observation
COMPLETED
Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.NCT01884675 · 2013-09-01 · 1 site observation
TERMINATED
Right Side of Heart Function After Lung SurgeryNCT01892800 · 2013-08-01 · 1 site observation
UNKNOWN
Ingenio Device Algorithm StudyNCT01441583 · 2011-10-01 · 1 site observation
COMPLETED
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)NCT01178073 · 2010-10-01 · 1 site observation
COMPLETED
Evaluation of Multisensor Data in Heart Failure Patients With Implanted DevicesNCT01128166 · 2010-06-01 · 1 site observation
COMPLETED
Imatinib (QTI571) in Pulmonary Arterial HypertensionNCT00902174 · 2009-09-01 · 1 site observation
COMPLETED
An Observational Study For AmbrisentanNCT00679224 · 2008-06-01 · 1 site observation
COMPLETED
A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 DiabetesNCT00672386 · 2007-12-01 · 1 site observation
COMPLETED
An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of GalantamineNCT00297414 · 2004-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.